MARKET

ALKS

ALKS

Alkermes
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.87
-0.24
-1.19%
After Hours: 19.87 0 0.00% 17:26 11/11 EST
OPEN
19.99
PREV CLOSE
20.11
HIGH
20.14
LOW
19.67
VOLUME
1.81M
TURNOVER
--
52 WEEK HIGH
37.98
52 WEEK LOW
17.11
MARKET CAP
3.13B
P/E (TTM)
-15.4883
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALKS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 12 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ALKS News

  • Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates
  • Zacks.3d ago
  • Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis
  • Zacks.3d ago
  • Global Blood's (GBT) Q3 Loss Widens, Voxelotor in Focus
  • Zacks.3d ago
  • Clovis (CLVS) Q3 Earnings & Sales Beat Estimates, Shares Up
  • Zacks.3d ago

More

Industry

Biotechnology & Medical Research
-0.40%
Pharmaceuticals & Medical Research
-0.41%

Hot Stocks

Name
Price
%Change

About ALKS

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.
More

Webull offers Alkermes Plc (ALKS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.